Evidence map›Paper›PMID 40725209›Full record

ArticleInternational journal of molecular sciences2025

Anti-Obesity Effects of

Jung Min Kim, Kyoung Kon Kim, Hye Rim Lee, Jae Cheon Im, Tae Woo Kim

Erratum issuedAbstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Correction: Kim et al. Anti-Obesity Effects ofInternational journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Jung Min KimNewgen Healthcare Co., Ltd., Chuncheon-si 24232, Republic of Korea.
Kyoung Kon KimNewgen Healthcare Co., Ltd., Chuncheon-si 24232, Republic of Korea.
Hye Rim LeeNewgen Healthcare Co., Ltd., Chuncheon-si 24232, Republic of Korea.
Jae Cheon ImNewgen Healthcare Co., Ltd., Chuncheon-si 24232, Republic of Korea.
Tae Woo KimNewgen Healthcare Co., Ltd., Chuncheon-si 24232, Republic of Korea.

Funding

Gangwon Science and Technology Promotion RS-2025-02173090
6 · The paper itself

Abstract

In modern society, obesity and its associated complications have emerged as serious public health concerns, primarily stemming from sedentary lifestyles and carbohydrate-rich diets. Due to the severe side effects often associated with pharmacological anti-obesity agents, emerging global efforts focus on preventive strategies, e.g., dietary modifications and weight gain-suppressing functional foods. In this context, plant-derived metabolites are extensively investigated for their beneficial anti-obesity effects. In this study, we evaluated how

Indexed as

AdipocytesAnti-Obesity AgentsFlowersLipid MetabolismObesityPlant ExtractsRosa3T3-L1 CellsAnimalsDiet, High-FatEnergy MetabolismLipogenesisLipolysisMaleMiceRatsAnti-Obesity AgentsPlant Extractshigh-fat dietlipid metabolismNG-RR-T1FobesityRosa rugosa Thunb. flower bud

Identifiers

PMID40725209
PMCPMC12294851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.